Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Studying Treatments in Patients Receiving Androgen Deprivation Therapy (ADT) for Metastatic Prostate Cancer: Evaluation of Drug and Radiation Efficacy: A 2nd Multi-arm Multi-stage Randomised Controlled Trial (STAMPEDE2).

NCT06320067 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT06320067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06320067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Studying Treatments in Patients Receiving Androgen Deprivation Therapy (ADT) for Metastatic Prostate Cancer: Evaluation of Drug and Radiation Efficacy: A 2nd Multi-arm Multi-stage Randomised Controlled Trial (STAMPEDE2).
Lead sponsor
University College, London
Phase
Phase 3
Overall status
Recruiting
Start date
June 11, 2024
Completion date
March 31, 2032
Enrollment
3,360 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer metastatic